Siddhivinayak Taimes Shimla PGIMER Chandigarh proudly announces that Dr Parth Lal, MD, Paediatrics Resident has been honoured with the prestigious “2025 Suzanne and Peter Berry International Travel Award” by the American Epilepsy Society (AES). This award, presented to only two exceptional young investigators worldwide from Asia, Africa, Oceania, the Middle East, or Latin America, recognizes outstanding contributions to clinical neuroscience research in epilepsy. Dr Lal’s selection from over 1,500 international submissions highlights the global significance and high scientific merit of his work. Dr Lal was recognized for his groundbreaking study, “Comparison of Effectiveness and Safety of Nitrazepam Versus Topiramate in Resistant Infantile Epileptic Spasms Syndrome: An Open-Label, Randomized Controlled Trial.” Conducted as part of his MD dissertation, the research provides the highest level of clinical evidence (Class I) for guiding treatment in infants with refractory epileptic spasms—one of the most severe and challenging forms of childhood epilepsy. The findings are expected to have a direct impact on clinical practice, offering evidence-based treatment options where robust comparative data has been limited.
Read This:https://sidhivinayaktimes.com/kanwai-performancedances-madethird-eveninarnival-memorable/
As part of the award, Dr Lal presented his work at the Annual Meeting of the American Epilepsy Society in Atlanta, USA, sharing PGIMER’s research excellence with leading global experts in neurology and paediatrics. Expressing his gratitude, Dr Lal said, “This recognition is deeply humbling. I am thankful to PGIMER for its supportive academic environment and to my mentors for their guidance. Most importantly, this work is dedicated to children with resistant epilepsy and their families.”The research was conducted under the mentorship of Dr Jitendra Sahu, Professor of Paediatric Neurology, Advanced Paediatric Centre, PGIMER, who praised Dr Lal’s scientific rigour and clinical dedication. This international recognition not only underscores Dr Lal’s potential as a clinician-scientist but also reinforces PGIMER Chandigarh’s growing role in high-impact paediatric neuroscience research and its commitment to nurturing young investigators shaping the future of evidence-based medicine.
Loading ...
